Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Articles
Leukemia
,
Oncology
Investigational Blinatumomab Puts BiTE on Acute Lymphoblastic Leukemia
Read More
Radiologic Surveillance for Early-Stage Hodgkin Lymphoma an Unnecessary Expense?
Read More
A Large Study Sheds Light on the Cost of Managing NHL
Read More
Second-Generation TKIs Have Potential to Cure CML
Read More
Hematologists Are Told to Get Ready for ACOs
Read More
Chronic Myeloid Leukemia: Are We Close to Finding a Cure?
Read More
Hematologic Pipeline Abundant
Read More
Conference Highlights ASH
VTE Prophylaxis during Chemotherapy Cost-Effective
Read More
Conference Highlights ASH
Favorable Data for Ruxolitinib and for a New JAK Inhibitor in Myelofibrosis
Read More
Multiple Myeloma
,
Multiple Myeloma
,
Oncology
Next-Generation Proteasome Inhibitors Cause Less Peripheral Neuropathy
Read More
205
206
207
208
209
210
211
Page 208 of 244
Results 2071 - 2080 of 2434